Welcome to our dedicated page for Inspira Tech SEC filings (Ticker: IINNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Clinical-trial updates, FDA timelines, and dilution clauses for Inspira Technologies often hide in dense 10-K tables and sudden 8-K releases. If you have searched “Where is Inspira Technologies’ quarterly earnings report 10-Q filing?” or tried decoding “Inspira Technologies insider trading Form 4 transactions,” you know how difficult it is to surface the data that moves this intravascular oxygenation pioneer. Stock Titan’s AI-powered summaries read every page the moment it hits EDGAR, translating biomedical jargon into clear insight so you can focus on decisions, not document hunting.
The hub streams every disclosure for the ordinary shares (IINN) and the warrants (IINNW) with real-time filing updates. Explore the cash-burn narrative inside the “Inspira Technologies annual report 10-K simplified,” follow HYLA blood-sensor cost trends through our “Inspira Technologies earnings report filing analysis,” or receive instant alerts for “Inspira Technologies Form 4 insider transactions real-time.” Need context on fresh capital? The platform highlights warrant exercises and shelf registrations in “Inspira Technologies 8-K material events explained.” Executive pay details are one click away via the “Inspira Technologies proxy statement executive compensation,” all annotated so you see option grants and vesting schedules at a glance.
Professionals use these insights to monitor executive stock transactions Form 4 before pivotal trial readouts, benchmark quarter-over-quarter R&D spend against regulatory milestones, and track segment revenue potential for disposable kits. Understanding Inspira Technologies SEC documents with AI removes complexity, letting you gauge clinical momentum, dilution risk, and insider sentiment in minutes.
Inspira Technologies Oxy B.H.N. Ltd. submitted a Form 6-K that incorporates by reference previously filed registration statements and furnishes a press release dated September 18, 2025. The press release announces that Inspira will unveil its HYLA™ real-time blood sensor at the U.S. ELSO conference and states the device has 97.35% accuracy confirmed. The filing is signed by Chief Executive Officer Dagi Ben-Noon. The document provides an event announcement and a specific accuracy figure for the product but does not include financial results, commercialization details, regulatory approvals, or timelines.
Inspira Technologies Oxy B.H.N. Ltd. disclosed a press release announcing that its HYLA™ blood sensor achieved 97.35% accuracy. The company states this result as an advance toward a planned FDA submission for clearance, signaling progress in regulatory milestones for the device. The filing incorporates that press release into the Form 6-K report.
The information provided is limited to the accuracy result and the intended regulatory step; no financial results, timelines, trial sizes, or additional performance metrics are included in the filing.
Inspira Technologies Oxy B.H.N. Ltd. disclosed a press release dated September 2, 2025 announcing that a top U.S. Honor Roll hospital has expanded clinical use of the company’s INSPIRA™ ART100 system to include lung transplant procedures. The filing reproduces the press release and is signed by Dagi Ben-Noon, Chief Executive Officer. The statement highlights broader clinical adoption of the ART100 device but does not provide revenue, patient counts, contract terms, or trial results in this filing.
Inspira Technologies Oxy B.H.N. Ltd. announced a binding purchase order from a government customer for $27 million of ART100 systems, with the company stating that full payment will be received in 2025. The notice, filed as a Form 6-K and dated August 19, 2025, is signed by Chief Executive Officer Dagi Ben-Noon. The release communicates a material commercial win and a confirmed cash inflow timing without providing further operational or delivery details.
FAQ
What is the current stock price of Inspira Tech (IINNW)?
